AngioDynamics (ANGO) Competitors $8.56 -0.30 (-3.39%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$8.90 +0.34 (+3.97%) As of 08/1/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANGO vs. TMO, WST, IART, SRDX, OFIX, ARAY, RMTI, RSLS, ABT, and ISRGShould you be buying AngioDynamics stock or one of its competitors? The main competitors of AngioDynamics include Thermo Fisher Scientific (TMO), West Pharmaceutical Services (WST), Integra LifeSciences (IART), Surmodics (SRDX), ORTHOFIX MEDICAL (OFIX), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "medical" sector. AngioDynamics vs. Its Competitors Thermo Fisher Scientific West Pharmaceutical Services Integra LifeSciences Surmodics ORTHOFIX MEDICAL Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical AngioDynamics (NASDAQ:ANGO) and Thermo Fisher Scientific (NYSE:TMO) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, earnings, media sentiment, risk, dividends and valuation. Which has more risk & volatility, ANGO or TMO? AngioDynamics has a beta of 0.6, indicating that its stock price is 40% less volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500. Does the media refer more to ANGO or TMO? In the previous week, Thermo Fisher Scientific had 58 more articles in the media than AngioDynamics. MarketBeat recorded 66 mentions for Thermo Fisher Scientific and 8 mentions for AngioDynamics. Thermo Fisher Scientific's average media sentiment score of 1.17 beat AngioDynamics' score of 1.13 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AngioDynamics 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Thermo Fisher Scientific 43 Very Positive mention(s) 6 Positive mention(s) 10 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate ANGO or TMO? AngioDynamics presently has a consensus price target of $19.00, suggesting a potential upside of 121.96%. Thermo Fisher Scientific has a consensus price target of $593.00, suggesting a potential upside of 28.15%. Given AngioDynamics' stronger consensus rating and higher possible upside, equities research analysts plainly believe AngioDynamics is more favorable than Thermo Fisher Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AngioDynamics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Thermo Fisher Scientific 0 Sell rating(s) 6 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 2.71 Which has better earnings and valuation, ANGO or TMO? Thermo Fisher Scientific has higher revenue and earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAngioDynamics$292.50M1.19-$33.99M-$0.83-10.31Thermo Fisher Scientific$43.21B4.04$6.34B$17.2926.76 Is ANGO or TMO more profitable? Thermo Fisher Scientific has a net margin of 15.24% compared to AngioDynamics' net margin of -11.62%. Thermo Fisher Scientific's return on equity of 16.82% beat AngioDynamics' return on equity.Company Net Margins Return on Equity Return on Assets AngioDynamics-11.62% -3.20% -2.09% Thermo Fisher Scientific 15.24%16.82%8.38% Do institutionals & insiders have more ownership in ANGO or TMO? 89.4% of AngioDynamics shares are held by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are held by institutional investors. 5.4% of AngioDynamics shares are held by company insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryThermo Fisher Scientific beats AngioDynamics on 12 of the 16 factors compared between the two stocks. Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANGO vs. The Competition Export to ExcelMetricAngioDynamicsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$360.02M$6.76B$5.49B$9.52BDividend YieldN/A1.32%4.73%4.09%P/E Ratio-10.3120.9428.7823.81Price / Sales1.1954.12372.2066.04Price / Cash18.1920.5035.4557.96Price / Book1.904.468.275.54Net Income-$33.99M$174.54M$3.25B$259.28M7 Day Performance-7.16%-5.27%-3.70%-4.64%1 Month Performance-8.84%-3.94%4.34%4.41%1 Year Performance10.17%8.26%25.90%17.95% AngioDynamics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANGOAngioDynamics3.9585 of 5 stars$8.56-3.4%$19.00+122.0%+9.9%$360.02M$292.50M-10.31760Positive NewsTMOThermo Fisher Scientific4.9941 of 5 stars$484.90+1.4%$593.00+22.3%-25.6%$180.56B$42.88B28.05125,000Positive NewsAnalyst UpgradeWSTWest Pharmaceutical Services4.6202 of 5 stars$257.36-2.3%$320.71+24.6%-20.9%$18.93B$2.89B38.5310,600Positive NewsShort Interest ↑IARTIntegra LifeSciences4.2493 of 5 stars$13.10-0.1%$18.63+42.2%-50.0%$1.02B$1.61B-34.474,396Trending NewsEarnings ReportSRDXSurmodics3.8812 of 5 stars$36.66+1.8%$43.00+17.3%-12.8%$514.77M$126.08M-26.37450Positive NewsHigh Trading VolumeOFIXORTHOFIX MEDICAL2.6483 of 5 stars$11.40+1.2%$21.50+88.6%-31.7%$441.57M$799.49M-3.091,616Upcoming EarningsARAYAccuray3.2441 of 5 stars$1.39+2.2%N/A-24.3%$140.10M$446.55M0.001,040Positive NewsRMTIRockwell Medical4.1584 of 5 stars$1.03-3.7%$4.00+288.3%-47.8%$36.57M$101.49M0.00300RSLSReShape Lifesciences0.6707 of 5 stars$2.40-3.2%N/A-99.1%$5.92M$8.01M-0.0150ABTAbbott Laboratories4.983 of 5 stars$126.28-0.2%$144.47+14.4%+15.6%$220.16B$41.95B15.82114,000Positive NewsISRGIntuitive Surgical4.7396 of 5 stars$493.95-0.4%$592.05+19.9%+7.1%$177.75B$8.35B68.8915,638Positive NewsInsider Trade Related Companies and Tools Related Companies Thermo Fisher Scientific Competitors West Pharmaceutical Services Competitors Integra LifeSciences Competitors Surmodics Competitors ORTHOFIX MEDICAL Competitors Accuray Competitors Rockwell Medical Competitors ReShape Lifesciences Competitors Abbott Laboratories Competitors Intuitive Surgical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANGO) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AngioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANGO Stock Alerts